Laporan Laba Rugi VM4 - TTM - Vanda Pharmaceuticals Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Vanda Pharmaceuticals Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	241	248	253	259	268	269	266	263	258	254	257	238	212	193	178	182	191	199	201	203
Change (%)		2.78	1.88	2.25	3.79	0.14	-0.92	-1.32	-1.82	-1.37	0.91	-7.14	-11.12	-9.07	-7.81	2.49	4.85	4.15	1.30	1.05
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	23	23	24	25	26	26	25	25	24	24	23	21	18	15	13	13	12	11	11	11
Change (%)		0.81	3.52	2.97	3.61	-0.68	-1.42	-2.01	-1.93	0.01	-3.67	-10.94	-15.64	-15.81	-9.02	-5.69	-4.03	-7.14	0.72	0.03
% of Revenue	9.60	9.41	9.57	9.63	9.62	9.54	9.49	9.42	9.41	9.55	9.11	8.74	8.30	7.68	7.58	6.97	6.38	5.69	5.66	5.60

Gross Operating Profit	218	225	229	234	243	243	241	238	234	230	233	218	194	178	164	169	179	187	190	192
Change (%)		2.99	1.71	2.17	3.80	0.22	-0.87	-1.25	-1.81	-1.51	1.39	-6.76	-10.69	-8.46	-7.70	3.16	5.52	4.92	1.33	1.11
% of Revenue	90.40	90.59	90.43	90.37	90.38	90.46	90.51	90.58	90.59	90.45	90.89	91.26	91.70	92.32	92.42	93.03	93.62	94.31	94.34	94.40

SG&A	142	141	133	128	126	124	135	140	137	136	132	127	122	113	107	118	131	146	166	192
Change (%)		-1.02	-5.14	-4.18	-1.21	-1.68	8.91	3.44	-1.86	-0.48	-3.48	-3.49	-4.00	-7.51	-5.33	10.36	10.86	11.98	13.66	15.11
% of Revenue	58.79	56.62	52.72	49.40	47.02	46.17	50.75	53.20	53.18	53.65	51.32	53.34	57.61	58.60	60.17	64.79	68.50	73.66	82.65	94.15

R&D	54	56	56	64	71	75	80	81	87	86	84	79	71	77	79	79	79	74	89	94
Change (%)		3.30	1.09	13.07	11.58	6.32	6.42	1.55	6.39	-1.01	-2.02	-5.76	-10.43	8.30	2.50	0.02	0.22	-5.70	19.56	5.99
% of Revenue	22.28	22.39	22.22	24.57	26.42	28.05	30.13	31.00	33.59	33.72	32.74	33.23	33.48	39.88	44.33	43.27	41.36	37.45	44.20	46.36

OpEx	220	221	215	218	224	227	242	247	250	248	241	229	212	207	203	214	228	239	274	304
Change (%)		0.23	-2.62	1.16	3.08	0.97	6.86	2.23	0.86	-0.61	-2.97	-4.99	-7.26	-2.59	-1.84	5.77	6.45	4.86	14.36	11.13
% of Revenue	91.29	89.02	85.09	84.18	83.61	84.31	90.93	94.20	96.77	97.51	93.77	95.94	100.11	107.24	114.18	117.84	119.64	120.46	135.98	149.55

Operating Income	21	27	38	41	44	42	24	15	8	6	16	10	-0	-14	-25	-32	-37	-41	-72	-101
Change (%)		29.52	38.42	8.48	7.52	-4.13	-42.71	-36.88	-45.33	-24.08	152.84	-39.55	-102.37	5,992.58	80.55	28.90	15.41	8.50	78.19	39.14
% of Revenue	8.71	10.98	14.91	15.82	16.39	15.69	9.07	5.80	3.23	2.49	6.23	4.06	-0.11	-7.24	-14.18	-17.84	-19.64	-20.46	-35.98	-49.55

Interest Expense																	-1		-1	-2
Change (%)																				111.31
% of Revenue																	-0.47		-0.45	-0.95

Net Income	19	23	32	32	34	33	18	11	6	6	16	15	12	3	-5	-11	-16	-19	-44	-67
Change (%)		20.52	34.98	2.98	5.62	-3.25	-45.49	-39.17	-40.94	-3.34	154.29	-6.61	-21.02	-78.68	-294.86	123.50	49.98	15.33	134.12	51.28
% of Revenue	8.02	9.40	12.46	12.55	12.77	12.34	6.79	4.18	2.52	2.47	6.22	6.25	5.56	1.30	-2.75	-6.00	-8.59	-9.51	-21.98	-32.90

Source: Capital IQ

Vanda Pharmaceuticals Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings

US:VNDA	US$ 4.61
GB:0LKB